Former Global Marketing & Portfolio Strategy Lead, FARAPULSE Pulsed Field Ablation at Boston Scientific

Former Global Marketing and Portfolio Strategy leader at Boston Scientific focused on FARAPULSE Pulsed Field Ablation (2021–2025), with 4+ years of experience in electrophysiology and medical device strategy. Led upstream marketing, portfolio development, and market modeling for the PFA pipeline across multiple product lines including FARAWAVE Nav, FARAPOINT, and FARAFLEX, while supporting investor-facing strategy and international expansion planning in key markets including Japan and Brazil. Deep expertise in competitive positioning versus Medtronic, Biosense Webster, and Abbott, with additional visibility into reimbursement dynamics, ASC site-of-care economics, and post-acquisition integration strategy.